1.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints t...
by Kobayashi, Tohru, Dr
The Lancet (British edition), 2012, Vol.379 (9826), p.1613-1620

2.
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
by Blaha, Michael J, Dr
The Lancet (British edition), 2011, Vol.378 (9792), p.684-692

3.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

4.
Cardiovascular effects of marine omega-3 fatty acids
by Saravanan, Palaniappan, Dr
The Lancet (British edition), 2010, Vol.376 (9740), p.540-550

5.
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
by Chen, Shaojie
Heart, 2013-01, Vol.99 (2), p.76-82

6.
Lupus Atherosclerosis Prevention Study (LAPS)
by Petri, M A
Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.760-765

7.
Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial
by Singh, Ram B
The Lancet (British edition), 2002-11-09, Vol.360 (9344), p.1455-1461

8.
Flow-mediated vasodilation : A diagnostic instrument, or an experimental tool?
by MOENS, An L
Chest, 2005, Vol.127 (6), p.2254-2263

9.
Atherosclerosis: Disease Biology Affecting the Coronary Vasculature
by Libby, Peter
The American journal of cardiology, 2006, Vol.98 (12), p.S3-S9

10.
Role of Vitamin D in Cardiovascular Health
by Reddy Vanga, Subba, MBBS
The American journal of cardiology, 2010, Vol.106 (6), p.798-805

11.
Recent National Cholesterol Education Program Adult Treatment Panel III Update: Adjustments and Options
by Stone, Neil J
The American journal of cardiology, 2005, Vol.96 (4), p.53-59

12.
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCA...
by Girman, Cynthia J
The American journal of cardiology, 2004, Vol.93 (2), p.136-141

13.
Effects of Plant-Based Diets on Plasma Lipids
by Ferdowsian, Hope R., MD, MPH
The American journal of cardiology, 2009, Vol.104 (7), p.947-956

14.
Effect of Intensive Lifestyle Changes on Endothelial Function and on Inflammatory Markers of Atherosclerosis
by Dod, Harvinder S., MD
The American journal of cardiology, 2010, Vol.105 (3), p.362-367

15.
Appropriateness of Statins in Patients Aged ≥80 Years and Comparison to Other Age Groups
by Chokshi, Neel P., MD, MBA
The American journal of cardiology, 2012, Vol.110 (10), p.1477-1481

16.
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
by Hausenloy, D J
Heart (British Cardiac Society), 2008-06, Vol.94 (6), p.706-714

17.
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCE...
by Davidson, Michael H
The American journal of cardiology, 2005, Vol.96 (4), p.556-563

18.
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals
by HO, Jennifer E
AIDS (London), 2010, Vol.24 (12), p.1897-1905

19.
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
by G Steiner
The Lancet (British edition), 2001, Vol.357 (9260), p.905-910

20.
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
by Fang, James C
The Lancet (British edition), 2002, Vol.359 (9312), p.1108-1113
